top of page

PROVIDERS

Portrait of Dr. Robert Schwarcz, MD, renowned oculofacial plastic surgeon in Manhattan, NY, and Rye, NY, specializing in blepharoplasty, facelifts, brow lifts, and fat transfer procedures. Dr. Schwarcz is acclaimed for his expertise in eyelid surgery and advanced facial rejuvenation techniques.
Dr. Robert Schwarcz, MD, a renowned oculofacial plastic surgeon with offices in Manhattan's Upper East Side and Rye, NY. Specializing in blepharoplasty, facelifts, brow lifts, fat transfer procedures, and non-surgical facial rejuvenation treatments. Dr. Schwarcz is highly regarded for his expertise in cosmetic and reconstructive eyelid surgery, offering natural-looking results tailored to each patient.

LOCATIONS

  • Tepezza Infusion is an FDA-approved treatment for Thyroid Eye Disease (TED), a rare condition causing inflammation and swelling in the eye area. Delivered via intravenous infusion, Tepezza works to reduce eye bulging, double vision, and other symptoms by targeting and inhibiting the activity of the IGF-1 receptor, a key driver of TED.

  • Tepezza infusion treatment is suitable for individuals experiencing moderate to severe symptoms of thyroid eye disease (TED), including:

    • Proptosis (Eye Bulging): Patients with bulging eyes due to inflammation and swelling behind the eye sockets.

    • Eyelid Retraction: Individuals with eyelids that are pulled back or retracted, causing exposure of the whites of the eyes.

    • Eye Pain and Discomfort: Patients experiencing pain, discomfort, or pressure behind the eyes due to inflammation and swelling.

    • Double Vision: Individuals with double vision or other vision disturbances associated with thyroid eye disease.

  • While Tepezza infusion treatment can provide significant benefits for many patients with thyroid eye disease, certain individuals may not be suitable candidates for the treatment. You may not be a good candidate for Tepezza infusion treatment if you:

    • Have Certain Medical Conditions: Patients with certain pre-existing medical conditions or contraindications to Tepezza may not be eligible for treatment. Dr. Schwarcz will conduct a thorough evaluation to determine if Tepezza infusion is right for you.

    • Are Pregnant or Breastfeeding: Women who are pregnant, planning to become pregnant, or breastfeeding may need to postpone Tepezza infusion treatment until after pregnancy and lactation.

  • Tepezza infusion treatment involves a series of eight infusions administered intravenously, spaced at least three weeks apart. Here's what patients can expect during the course of treatment:

    1. Pre-Treatment Evaluation: Before starting Tepezza infusion treatment, Dr. Schwarcz will conduct a comprehensive evaluation of your thyroid eye disease symptoms, medical history, and overall health to ensure the treatment is appropriate for you.

    2. Infusion Sessions: During each infusion session, patients will receive Tepezza medication intravenously over the course of several hours. Dr. Schwarcz and his experienced medical team will monitor patients closely throughout the infusion process to ensure safety and efficacy.

    3. Post-Treatment Monitoring: Following each infusion session, patients will be monitored for any potential side effects or adverse reactions. Dr. Schwarcz will provide personalized post-treatment instructions and guidance to optimize the therapeutic benefits of Tepezza infusion.

  • After completing all eight Tepezza infusion sessions, patients can expect to experience gradual improvement in their thyroid eye disease symptoms over time. Many patients report significant reduction in proptosis (eye bulging), improvement in eyelid retraction, alleviation of eye pain and discomfort, and resolution of double vision.


    Dr. Schwarcz will schedule follow-up appointments to monitor your progress, assess treatment outcomes, and make any necessary adjustments to your ongoing care plan. With Tepezza infusion treatment, patients can achieve improved eye health, enhanced appearance, and enhanced quality of life.

Discover relief from the symptoms of thyroid eye disease (TED) with Tepezza in NYC, offered by Dr. Robert Schwarcz. Tepezza is the first FDA-approved medication specifically designed to treat thyroid eye disease, a condition that can cause bulging eyes, double vision, and discomfort. With extensive experience in oculofacial plastic surgery and the treatment of complex eye conditions, Dr. Schwarcz provides cutting-edge thyroid eye disease treatment in NYC to help patients regain both function and confidence.

Tepezza offers a non-surgical solution for those seeking effective TED treatment in NYC. This innovative medication works by targeting the inflammation and tissue changes associated with thyroid eye disease, offering significant improvements in symptoms like eye bulging and redness. At his conveniently located offices on the Upper East Side of Manhattan and in Rye, NY, Dr. Schwarcz delivers personalized care tailored to each patient's unique needs and condition severity.

If you're looking for a trusted provider of thyroid eye disease treatment in NYC, Dr. Schwarcz’s expertise ensures you receive the highest level of care. Schedule a consultation today to learn more about how Tepezza in NYC can help you manage your symptoms and improve your quality of life.

TEPEZZA INFUSION

bottom of page